This doesn't generate any revenue. In fact it'll be the reason to announce another secondary. They'll need cash to actually develop a therapy. Naturally that will take years.
Could be manipulation and if the share were trading at 38, I'd be in agreement. However, we've seen a steady decline since the secondary. Pushing the price down even more seems counter productive. Isn't this the time to push it higher and cash in on the huge decline of the past couple of months?
I just read a follow-up article that more clearly describes the results. Clearly the drug is not a cure; it simply slows the decline of muscle function. Like a treatment for hypertension, it does not seem to be a one-shot treatment, but was that ever the expectation?
Many drugs that fail to make it to market have side effects that override their benefits. In this case, that is not a concern.
I suspect we'll be arguing whether this is good or bad data for quite some time.
When the news broke, it appeared to be good. 5 minutes later it appeared to be bad. I haven't been able to discern what the key piece of information is in the update that is driving the price lower. Any thoughts?
Today's sell-off of ROSG is due to profit taking. Surely there must be someone who made a profit on ROSG. After all, while it is down 99% from the high, it is about 100% since the low in 2012.
If we have eternal life there is a slim chance that we'll be able to recover our losses. Of course, eternal life wouldn't provide much incentive for the current management team to retire.
I imagine that those smart investors who bought SRPT in the secondary priced at 38 are wondering if they made the right decision. It is normal to see a bit of a sell off on a secondary, but a 25% drop seems excessive, especially without any negative news.
The worst of the decline is that it now causes long holders to look for opportunities to get out with a somewhat reduced loss. That's what we've seen; every bump up is sold off.
I'd like to see it supported with some volume. This low volume makes it too easy for someone to reverse this trend in a heartbeat.
Well this is actually a positive for young women. Otherwise companies would hire only older women beyond their child bearing years. ;-)
Yes, FB actually has a P/E. Still, you wonder if FB isn't simply a social trend that will be replace by something else in the near future.
And of course those people who think their money is safe when invested in gov't debt get no interest in exchange for massive risk.